Craving: A research update. Editorial to a Special Issue.

Addictive Behaviors

Volumn 38, Issue 2, 2013, Pages 1499-1500

  Kavanagh, David J ^a   Connor, Jason P ^b  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MODAFINIL;

AMBIVALENCE; ANTERIOR CINGULATE; COGNITION; EDITORIAL; HUMAN; PSYCHOMETRY; PUTAMEN; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SUBSTANCE ABUSE; WITHDRAWAL SYNDROME; WORKING MEMORY;

EID: 84871785087     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2012.08.001     Document Type: Editorial

References (16)

1. Anderson A.L., Reid M.S., Li S.H., Holmes T., Shemanski L., Slee A., et al. Modafinil for the treatment of cocaine dependence. Drug and Alcohol Dependence 2009, 104:133-139.
2. Andrade J., May J., Kavanagh D.J. Sensory imagery in craving: From cognitive psychology to new treatments for addiction. Journal of Experimental Psychopathology 2012, 3(2):127-145. 10.5127/jep. 024611.
3. Andrade J., Pears S., May J., Kavanagh D.J. Use of a clay modeling task to reduce chocolate craving. Appetite 2012, 58:955-963.
4. Anton R.F., Moak D.H., Latham P. The Obsessive Compulsive Drinking Scale: A self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcoholism, Clinical and Experimental Research 1995, 19:92-99.
5. American Psychiatric Association DSM-5 development Accessed 8 August, 2012. http://www.dsm5.org.
6. Hasin D.S., Fenton M.C., Beseler C., Park J.Y., Wall M.M. Analyses related to the development of DSM-5 criteria for substance use related disorders: 2. Proposed DSM-5 criteria for alcohol, cannabis, cocaine and heroin disorders in 663 substance abuse patients. Drug and Alcohol Dependence 2012, 122(1-2):28-37.
7. Johnson B.A. Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings. Biochemical Pharmacology 2008, 75(1):34-56.
8. Kamboj S.K., Joye A., Das R.K., Gibson A.J.W., Morgan C.J.A. Cue exposure and response prevention with heavy smokers: A laboratory-based randomised placebo-controlled trial examining the effects of d-cycloserine on cue reactivity and attentional bias. Psychopharmacology 2012, 221(2):273-284.
9. Kamboj S.K., Massey-Chase R., Rodney L., Das R., Almahdi B., Curran H.V., et al. Changes in cue reactivity and attentional bias following experimental cue exposure and response prevention: A laboratory study of the effects of d-cycloserine in heavy drinkers. Psychopharmacology 2011, 217(1):25-37.
10. Kavanagh D.J., Andrade J., May J. Imaginary relish and exquisite torture: The elaborated intrusion theory of desire. Psychological Review 2005, 112:446-467.
11. Keyes K.M., Krueger R.F., Grant B.F., Hasin D.S. Alcohol craving and the dimensionality of alcohol disorders. Psychological Medicine 2011, 41(3):629-640.
12. Maude-Griffin P.M., Tiffany S.T. Prediction of smoking urges through imagery: The impact of affect and smoking abstinence. Experimental and Clinical Psychopharmacology 1996, 4:198-208.
13. Norberg M.M., Krystal J.H., Tolin D.F. A meta-analysis of d-cycloserine and the facilitation of fear extinction and exposure therapy. Biological Psychiatry 2008, 63(12):1118-1126.
14. Palfai T.P., Monti P.M., Colby S.M., Rohsenow D.J. Effects of suppressing the urge to drink on the accessibility of alcohol outcome expectancies. Behaviour Research and Therapy 1997, 35:59-65.
15. Tiffany S.T., Wray J.M. The clinical significance of drug craving. Annals of the New York Academy of Sciences 2012, 1248:1-17. 10.1111/j.1749-6632.2011.06298.x.
16. Watson B.J., Wilson S., Griffin L., Kalk N.J., Taylor L.G., Munafo M.R., et al. A pilot study of the effectiveness of d-cycloserine during cue-exposure therapy in abstinent alcohol-dependent subjects. Psychopharmacology 2011, 216(1):121-129.